A key driver of our work was the goal of grounding the final TFOS DEWS II report in evidence-based medicine as a means of enabling broad adoption, free of influence or ambiguity. It is the fervent wish of all involved that this effort may translate into better clinical protocols that bring our patients sustained, long-term relief.
- J. Daniel Nelson, MD, TFOS DEWS II Chair
Above this introduction, you can find digital and PDF editions of Review of Optometry's special report on TFOS DEWS II. Additionally, you can read the individual articles by clicking the links below:
A Definitive Decade for Dry Eye
A new era has arrived for CsA, with the powerful combination of a higher concentration offered in conjunction with advanced drug delivery technology. This important clinical development is giving eye care practitioners another tool to help manage the chronic and inflammatory nature of DED for their patients.